Jason Lettmann - Feb 19, 2025 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Shelly Pinto, by power of attorney
Stock symbol
ALXO
Transactions as of
Feb 19, 2025
Transactions value $
-$2,483
Form type
4
Date filed
2/21/2025, 04:20 PM
Previous filing
Jan 23, 2025
Next filing
Mar 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Sale -$2.48K -2.16K -1.25% $1.15 170K Feb 19, 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2024.